An inverse relationship between thyroglobulin (Tg) and urinary iodine concentration (UIC) has been found in children potentially making Tg a viable blood marker of iodine status. The application of Tg in adults is unknown.
To determine the efficacy of Tg to assess iodine status in adults.
A randomized, double-blind, placebo-controlled, clinical trial.
Dunedin, New Zealand.
Mildly iodine deficient (n=112) adults aged 18-40 years.
Participants were supplemented with 150 μ g of iodine as potassium iodate (KIO3) or placebo daily for 24 wk. At baseline and 24 wk, participants provided five casual urine samples for UIC determination; serum TSH and FT4 was also measured. Tg was determined at baseline and 8, 16 and 24 wk.
A change in Tg concentration between the iodine-supplemented and placebo groups at 24 wk.
At baseline, the overall median UIC was 65 μ g/L confirming that participants were mildly iodine deficient (i.e. median UIC between 50-99 μ g/L). The overall median Tg was 16.6 μ g/L; TSH and FT4 were within normal reference ranges. At 24 wk, the median UIC of the placebo and supplemented groups were significantly different, 79 and 168 μ g/L, respectively (P<0.001). Tg in the iodine-supplemented group decreased by 12, 20 and 27% compared to placebo group at 8 (P=0.045), 16 (P<0.001) and 24 wk (P<0.001); there were no significant changes in TSH and FT4.
Improved iodine status as assessed by UIC was associated with a concomitant decrease in Tg concentration, demonstrating that Tg is a useful biomarker of iodine status in a group of adults.